Simulations Plus, Inc. $SLP Shares Sold by Tributary Capital Management LLC

Tributary Capital Management LLC lowered its position in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 8.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 520,855 shares of the technology company’s stock after selling 47,635 shares during the quarter. Tributary Capital Management LLC’s holdings in Simulations Plus were worth $9,495,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the company. Raymond James Financial Inc. purchased a new stake in shares of Simulations Plus in the second quarter valued at approximately $25,000. Quarry LP purchased a new stake in shares of Simulations Plus in the third quarter valued at approximately $28,000. CWM LLC grew its position in shares of Simulations Plus by 3,729.1% in the third quarter. CWM LLC now owns 2,106 shares of the technology company’s stock valued at $32,000 after purchasing an additional 2,051 shares in the last quarter. Farther Finance Advisors LLC purchased a new stake in shares of Simulations Plus in the third quarter valued at approximately $40,000. Finally, US Bancorp DE grew its position in shares of Simulations Plus by 32.5% in the third quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after purchasing an additional 1,513 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Stock Up 1.8%

NASDAQ:SLP opened at $14.37 on Friday. The stock’s fifty day moving average is $12.35 and its two-hundred day moving average is $15.94. Simulations Plus, Inc. has a 52 week low of $11.09 and a 52 week high of $36.45. The stock has a market capitalization of $290.35 million, a price-to-earnings ratio of -4.59 and a beta of 1.19.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Thursday, April 9th. The technology company reported $0.35 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The company had revenue of $24.29 million for the quarter, compared to analysts’ expectations of $21.66 million. On average, sell-side analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on SLP shares. Zacks Research lowered Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. TD Cowen dropped their price target on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Citigroup restated a “market perform” rating on shares of Simulations Plus in a research report on Tuesday, January 6th. Finally, Wall Street Zen lowered Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, April 4th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $24.40.

Simulations Plus Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.